| Drospirenone3mg + EE 0,03mg |
21 o 21+7 tablets |
Sales leader (Progestagen of 4th Generation). Anti-mineralocorticoid profile (no weight gains). Minimum side effects (spotting, breast tension). |
| Drospirenone3mg + EE 0,03mg |
24 + 4 tablets |
Sales leader (Progestagen of 4th Generation). Anti-mineralocorticoid profile (no weight gains). Minimum side effects (spotting, breast tension). |
| Desogestrel 75 µg |
228 tablets |
Progestan only. Suitable for breast-feeding women. Suitable for women with potential risk factors to use COSs. |
| Dienogest 2mg + EE 0,03mg |
21 o 21+7 tablets |
Excelent antiandrogenic profile. Peripheral action in ovaries and endometrium. Possible antiacne indication. |
| Chlormadinone 2mg + 0,03mg |
21 o 21+7 tablets |
Good antiandrogenic profile. Low side effects. |
| Desogestrel 0,150mg + EE 0,02mg |
21 tablets |
Wide range of prescriptions. Good tolerability and low side effects. |
| Desogestrel 0,150mg + EE 0,02mg |
21 tablets |
Wide range of prescriptions. Good tolerability and low side effects. |